首页> 外国专利> Use of a compound of depsipeptide derivative dolastina - 15 (Dov nmeval Val Pro Pro Hiva - dpy) for the preparation of a Pharmaceutical composition for the treatment of rheumatoid arthritis in a MamiferOr

Use of a compound of depsipeptide derivative dolastina - 15 (Dov nmeval Val Pro Pro Hiva - dpy) for the preparation of a Pharmaceutical composition for the treatment of rheumatoid arthritis in a MamiferOr

机译:Depsipeptide衍生物dolastina-15(Dov nmeval Val Pro Pro Hiva-dpy)化合物在制备用于治疗MamiferOr类风湿性关节炎的药物组合物中的用途

摘要

Use of a compound derived depsipeptide Dolastatin 15 (Dov nmeval Val Pro Pro Hiva - dpy) of formula (i) r1r2n CHX - CO - A - B - D - S - (e) (f) (g) - T - u K where: R1 is alkyl cycloalkyl, c1-3;As ciclopropilo; alquilsulfonilo c1-3; fluoroalquilo, as fluoroetilo, difluoretilo, fluoroisopropilo, aminosulfonilo which can be replaced by alkyl,As Methyl alkyl; R2 is Hydrogen, C1 - 3; fluoroalquilo, as fluoroetilo, difluoroetilo, cycloalkyl, fluorisopropilo;Such comociclopropilo; R1 - R2 together can be a Waste pirrolidino or piperidino; is a valilo, isoleucilo, leucilo, isoleucilo - 2.2 - dimetilglicilo, 2 - ciclopropilglicilo,Ciclopentilglicilo 2 -, 3 - butilalanilo ter ter butilglicilo -, 2 -, 3 - cicloexilalanilo2 etilglicilo ciclohexilglicilo -, 2 -, or norvalilo norleucilo residue; b is an n - alkyl - norvalilo - leucilo valilo,,,- isoleucilo - ter - butilglicilo, - 2, - 3 - ter - etilglicilo butilalanilo, - 2, - 2 - ciclopropilglicilo,Norleucilo or residue - 2 - N - alkyl is preferably ciclohexilglicilodonde N - or N - Methyl ethyl propyl; D and E, homoprolilo, hidroxiprolilo, 3,4 - deshidroprolilo fluoroprolilo 3 -, 4 -, metilprolilo,Metilprolilo 4 -, 5 - metilprolilo azetidin - 2 -, carbonyl - dimetilprolilo, 3.3, 4.4 - difluoroprolilo,Oxalidin carbonyl or tiazolidin residue - 4 - 4 - carbonyl; F and G are selected from the group consisting of prolilo Regardless, homoprolilo, hidroxiprolilo,Tiazolidinil - 4 - 1 - - - carbonilo1 aminopentil carbonyl, valilo butilglicilo ter -, 2 -, 3 - isoleucilo, leucilo, ciclohexilalanilo, fenilalanilo, N - metilfenilalanilo, tetrahidroisoquinolil - 2 - histidilo,1 - aminoindil carbonyl - 1 - 2 -, 3 - piridilalanilo, ciclohexilglicilo, norleucilo, norvalilo, neopentilglicilo, tritofanilo, glicilo, 2.2 - dimetilglicilalanilo,3 - beta - alanilo and waste naftilalanilo; X is (such as Hydrogen, alkyl, cycloalkyl c1-5) (such as C3 - 7), - CH2 - cyclohexyl or arylalkyl (such
机译:式(i)r1r2n CHX-CO-A-B-D-S-(e)(f)(g)-T-u K的化合物衍生的depsipeptide Dolastatin 15(Dov nmeval Val Pro Pro Hiva-dpy)的用途式中:R1为烷基环烷基,c1-3;为环丙基。 Alquilsulfonilo c1-3;氟代烷基,如氟代,二氟代,氟代异丙基,氨基磺酰基,可以被烷基取代为甲基烷基; R 2是氢,C 1-3;氟喹啉基,如氟代硬脂基,二氟代硬脂基,环烷基,氟代异丙基; R1-R2一起可以是废物吡咯烷酮或哌啶子基;是一个瓦利洛,异欧卢西洛,亮欧卢,异欧卢西洛-2.2-二美托基利基洛,2-环丙丙胺基洛基,西氯替丁利基洛2-,3-丁拉尼基叔丁醇-,2-,3-环氯埃西兰尼洛2 etilgliciloilo环戊基西洛基洛洛基,, 2-,or b是正烷基-正戊基-勒卢西洛valilo,-,-异油烯基-叔-butilglicilo,-2,-3-叔-etilglicilo butilalanilo,-2,-2-环丙丙胺基,Norleucilo或残基-2-N-烷基是优选的是环己基硅氧烷基的N-或N-甲基乙基丙基; D和E,高脯氨酸,羟脯氨酰氟,3,4--氟代去甲吡咯啉3-,4-,甲丙脯氨酰,甲氧基脯氨酰4-,5-甲丙脯氨酰氮杂环丁烷-2-,羰基-二甲脯氨酰氟,3.3,4.4-二氟脯氨酰,羟考啶残基4-4-羰基; F和G选自脯氨酰,同脯氨酰,hidroxiprolilo,噻唑烷腈-4-1---羰基氨基氨基羰基羰基,valilo butilglicilo ter-,2-,3-异噻咯咯啉,leucilo,ciclohexilalanlanilo,fenilalanilo,N-metilfenilailalo ,四氢异喹啉-2-组氨酸,1-氨基吲哚羰基-1-2-,3-piridilalanilo,ciclohexilglicilo,norleucilo,norvalilo,neopentilglicilo,tritofaniloilo,glicilo,2.2-dimetilglicilalanilo,3-β-alanilo和废萘菲拉X是(例如氢,烷基,环烷基c1-5)(例如C3-7),-CH2--环己基或芳基烷基(例如

著录项

  • 公开/公告号AR017298A1

    专利类型

  • 公开/公告日2001-09-05

    原文格式PDF

  • 申请/专利权人 BASF AKTIENGESELLSCHAFT;

    申请/专利号AR1998P104972

  • 发明设计人

    申请日1998-10-06

  • 分类号A61K38/08;A61K39/395;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号